Latest news
Qnovia Secures Worldwide License For Antimicrobial Peptide Targeting Drug-Resistant Infections - Pulse 2.0Pulse 2.0 · Wed, 05 Aug 2026 16:46:50 GMTKing’s researchers analyse global antimicrobial resistance threats over the next two decades - Roar NewsRoar News · Tue, 04 Aug 2026 15:12:07 GMTQnovia licenses novel antimicrobial peptide - PharmaTimesPharmaTimes · Tue, 04 Aug 2026 11:03:57 GMTBioHealth Capital Region – Regional Life Sciences Roundup – July 31st, 2026 - BioBuzzBioBuzz · Fri, 31 Jul 2026 12:58:01 GMTQnovia Secures Worldwide Exclusive License to Novel Antimicrobial Peptide from the University of Virginia - PR NewswirePR Newswire · Wed, 29 Jul 2026 07:00:00 GMT